REGENERX BIOPHARMACEUTICALS INC Quarterly Return On Assets in % from Q1 2012 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Return On Assets history and growth rate from Q1 2012 to Q1 2023.
  • Regenerx Biopharmaceuticals Inc Return On Assets for the quarter ending March 31, 2023 was -358 %, a 224% decline year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Return On Assets for 2022 was -260 %, a 116% decline from 2021.
  • Regenerx Biopharmaceuticals Inc annual Return On Assets for 2021 was -120 %, a 60.5% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Return On Assets for 2020 was -305 %, a 101% decline from 2019.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -358 -248 -224% Jan 1, 2023 Mar 31, 2023
Q4 2022 -260 -139 -116% Oct 1, 2022 Dec 31, 2022
Q3 2022 -201 -67.9 -51.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -162 +12.5 +7.15% Apr 1, 2022 Jun 30, 2022
Q1 2022 -110 +259 +70.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -120 +185 +60.5% Oct 1, 2021 Dec 31, 2021
Q3 2021 -133 +147 +52.5% Jul 1, 2021 Sep 30, 2021
Q2 2021 -174 +37.5 +17.7% Apr 1, 2021 Jun 30, 2021
Q1 2021 -370 -209 -129% Jan 1, 2021 Mar 31, 2021
Q4 2020 -305 -153 -101% Oct 1, 2020 Dec 31, 2020
Q3 2020 -279 -118 -72.9% Jul 1, 2020 Sep 30, 2020
Q2 2020 -212 -12.9 -6.47% Apr 1, 2020 Jun 30, 2020
Q1 2020 -161 +83.9 +34.2% Jan 1, 2020 Mar 31, 2020
Q4 2019 -152 +182 +54.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -162 -108 -202% Jul 1, 2019 Sep 30, 2019
Q2 2019 -199 +45.7 +18.7% Apr 1, 2019 Jun 30, 2019
Q1 2019 -245 -54.5 -28.6% Jan 1, 2019 Mar 31, 2019
Q4 2018 -334 -423 -473% Oct 1, 2018 Dec 31, 2018
Q3 2018 -53.5 +94.4 +63.8% Jul 1, 2018 Sep 30, 2018
Q2 2018 -244 -453 -217% Apr 1, 2018 Jun 30, 2018
Q1 2018 -191 -540 -155% Jan 1, 2018 Mar 31, 2018
Q4 2017 89.3 +65.4 +273% Oct 1, 2017 Dec 31, 2017
Q3 2017 -148 -45.1 -43.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 209 +610 Apr 1, 2017 Jun 30, 2017
Q1 2017 349 +1.87K Jan 1, 2017 Mar 31, 2017
Q4 2016 24 +767 Oct 1, 2016 Dec 31, 2016
Q3 2016 -103 +497 +82.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 -402 -16.4 -4.27% Apr 1, 2016 Jun 30, 2016
Q1 2016 -1.52K -1.3K -576% Jan 1, 2016 Mar 31, 2016
Q4 2015 -743 -492 -196% Oct 1, 2015 Dec 31, 2015
Q3 2015 -600 -344 -135% Jul 1, 2015 Sep 30, 2015
Q2 2015 -385 +29.3 +7.07% Apr 1, 2015 Jun 30, 2015
Q1 2015 -225 +379 +62.7% Jan 1, 2015 Mar 31, 2015
Q4 2014 -251 +252 +50.1% Oct 1, 2014 Dec 31, 2014
Q3 2014 -256 +103 +28.7% Jul 1, 2014 Sep 30, 2014
Q2 2014 -415 -14.3 -3.56% Apr 1, 2014 Jun 30, 2014
Q1 2014 -605 -315 -109% Jan 1, 2014 Mar 31, 2014
Q4 2013 -503 -183 -57.4% Oct 1, 2013 Dec 31, 2013
Q3 2013 -359 +234 +39.5% Jul 1, 2013 Sep 30, 2013
Q2 2013 -400 +466 +53.8% Apr 1, 2013 Jun 30, 2013
Q1 2013 -290 +155 +34.8% Jan 1, 2013 Mar 31, 2013
Q4 2012 -320 Oct 1, 2012 Dec 31, 2012
Q3 2012 -593 Jul 1, 2012 Sep 30, 2012
Q2 2012 -867 Apr 1, 2012 Jun 30, 2012
Q1 2012 -445 Jan 1, 2012 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.